| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/03/2010 | US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators |
| 08/03/2010 | US7767432 Strain of sorangium cellulosum for generation of epothilone derivatives; antitumor agents |
| 08/03/2010 | US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename |
| 08/03/2010 | US7767219 Drug core encapsulated with multilayer polyelectrolyte shells |
| 08/03/2010 | US7767203 Bacillus coagulans hammer, digestive enzymes, and dietary fiber; administered as a dairy food |
| 08/03/2010 | CA2529746C Oral extended-release composition |
| 08/03/2010 | CA2528622C Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 08/03/2010 | CA2503201C Modified release compositions of milnacipran |
| 08/03/2010 | CA2502582C Pharmaceutical formulation of olanzapine |
| 08/03/2010 | CA2329627C Desensitizing dentifrice containing potassium and tin salts |
| 08/03/2010 | CA2227706C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 07/29/2010 | US20100190696 Treatment of t-cell mediated diseases |
| 07/29/2010 | US20100190232 Functional Mutations In Respiratory Syncytial Virus |
| 07/29/2010 | US20100189759 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
| 07/29/2010 | US20100189708 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/28/2010 | EP2210607A1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-piperidin-1-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer |
| 07/28/2010 | CN1871021B Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| 07/28/2010 | CN101787073A Methods and compositions for the treatment of gastrointestinal disorders |
| 07/27/2010 | US7763660 administering 1-(5-methyl-2-propan-2-ylcyclohexyl)oxy-3-piperidin-1-ylpropan-2-ol, for the treatment fungal infection in humans and mammals; inhibitors of the budded-to-hyphal transition of yeasts |
| 07/27/2010 | US7763653 comprising the free bases of the local anesthetics prilocaine, lidocaine and bupivacaine in a weight ratio of 40-60%/25-45%/10-25%, respectively, the resulting mixture being a homogenous liquid having a melting point below 20 degrees C. |
| 07/27/2010 | US7763597 Salts |
| 07/27/2010 | US7763466 Generating cells for cell replacement therapy |
| 07/27/2010 | US7763459 decellularization of an isolated tissue using solubilizing solutions comprising oxidizing agents, while substantially maintaining the biological, mechanical and biochemical properties of the matrices |
| 07/27/2010 | US7763259 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183643 Cancer vaccines containing epitopes of oncofetal antigen |
| 07/22/2010 | US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 07/22/2010 | US20100183582 Hemostatic compositions containing sterile thrombin |
| 07/21/2010 | EP1581056B1 Therapeutic retroviral vectors for gene therapy |
| 07/21/2010 | EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 07/21/2010 | CN1751031B HIV replication inhibiting pyrimidines |
| 07/21/2010 | CN101780092A Compounds and methods for delivery of prostacyclin analogs |
| 07/20/2010 | US7759382 such as N-{5-[1-(4-chloro-phenyl)-1-methyl-ethyl]-2H-pyrazol-3-yl}-2-[2-(3,5-difluoro-phenyl)-2-hydroxy-acetylamino]-propionamide, used for inhibiting beta-amyloid peptide release and/or biosynthesis, inhibiting gamma-secretase activity, prevention and treatment of Alzheimer's disease |
| 07/20/2010 | US7759358 duplex carbonate prodrug; opiates or opiate antagonists; esterification with Phosgene to form corresponding carbonate; increase in transdermal flux; Bis-Naltrexone carbonate; increased permeability or solubility though biotransformation by enzymes or hydrolysis into two drug molecules; transdermal patch |
| 07/20/2010 | US7759328 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease |
| 07/20/2010 | US7759319 Oligomeric compounds and compositions for use in modulation of pri-mirnas |
| 07/20/2010 | US7758883 first layer has polyvinyl alcohol, polyvinyl acetate, and polyvinyl pyrrolidone; aqueous layer over the first layer;and a layer of a phospholipid (e.g., lecithin) over the aqueous layer; for treating dry eye syndrome |
| 07/20/2010 | US7758876 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/20/2010 | CA2529983C Preoperative treatment of post operative pain |
| 07/20/2010 | CA2287819C Shampoo composition comprising a lipophilic polysiloxane type uv-b screening agent |
| 07/15/2010 | US20100178315 Polymeric systems for controlled drug therapy |
| 07/14/2010 | EP2206514A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 07/13/2010 | US7754733 specific crystalline polymorphic form of the pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride (or 9-dimethylaminomethyl-10-hydroxycamptothecin monohydrochloride pentahydrate) |
| 07/13/2010 | US7754684 Macromolecular platinum chelates |
| 07/13/2010 | US7754500 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 07/13/2010 | US7754453 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 07/13/2010 | CA2522148C Thorium-227 for use in radiotherapy of soft tissue disease |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/13/2010 | CA2297345C Novel antigenic class of avian reoviruses |
| 07/08/2010 | US20100174304 Methods And Devices For Creating Electrical Block At Specific Targeted Sites In Cardiac Tissue |
| 07/08/2010 | US20100173917 Urea derivatives as abl modulators |
| 07/08/2010 | US20100173855 Dermatological Formulations |
| 07/08/2010 | US20100173413 Pyridine compounds |
| 07/08/2010 | US20100172974 Melt-extruded orally administrable opioid formulations |
| 07/07/2010 | EP2204187A1 Human flu vaccine containing four influenza peptides |
| 07/07/2010 | EP2204168A1 Once daily formulations of tetracyclines |
| 07/07/2010 | EP1622568B1 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 07/07/2010 | EP1620550B1 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 07/07/2010 | EP1096917B1 Non therapeutic use of N-acetylglucosamine as skin exfoliant |
| 07/06/2010 | US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds |
| 07/06/2010 | US7750050 Enhancing activity of an acid sphingomyelinase (ASM) protein with an analogue of ceramide, sphingomyelin or phosphonucleotide; gene therapy |
| 07/06/2010 | US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects |
| 07/06/2010 | US7750008 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis |
| 07/06/2010 | US7749990 [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, useful for the treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 07/06/2010 | US7749970 Application of an azalide antibiotic such as azithromycin |
| 07/06/2010 | US7749962 administering to mammal with breast cancer as adjuvant therapy an agent effective in blocking interaction of integrin with extracellular matrix protein of bone marrow microenvironment or that downregulates expression of integrin; integrin is alpha 5 beta 1 and extracellular matrix protein is fibronectin |
| 07/06/2010 | US7749958 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents |
| 07/06/2010 | US7749544 Plant extracts used as immunomodulators |
| 07/06/2010 | US7749540 Compositions comprising modafinil compounds |
| 07/06/2010 | US7749532 doxycycline; dosage forms have immediate release and delayed release portions; antiinflammatory, antiarthritic, and antidiabetic agents, periodontal disease, rosacea, acne, dry eyes, hyperparathyroidism |
| 07/06/2010 | US7749517 administering to a human or non-human animal infected by or exposed to anthrax a polypeptide that inhibits binding between protective antigen (PA) and human capillary morphogenesis protein-2 (CMG-2) at a level effective to reduce the severity of anthrax infection |
| 07/06/2010 | US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof |
| 07/06/2010 | CA2539479C Isoquinoline potassium channel inhibitors |
| 07/01/2010 | US20100169987 Animal model simulating neurologic disease |
| 07/01/2010 | US20100168397 Therapeutic use of anti-cs1 antibodies |
| 07/01/2010 | US20100168215 Methods and compositions for the treatment of neurological disease |
| 07/01/2010 | US20100168152 Fat regulation |
| 07/01/2010 | US20100168123 Akt protein kinase inhibitors |
| 07/01/2010 | US20100168085 Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells |
| 07/01/2010 | US20100167987 Methods and pharmaceutical compositions for healing wounds |
| 07/01/2010 | US20100167293 Digital Assay |
| 07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
| 06/30/2010 | EP2201947A2 Use of SAHA for treating mesothelioma |
| 06/30/2010 | CN101759645A P38 inhibitors and methods of use thereof |
| 06/29/2010 | US7745650 9,10-α,α-OH-taxane analogs and methods for production thereof |
| 06/29/2010 | US7745644 Antibiotic compounds |
| 06/29/2010 | US7745619 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease |
| 06/29/2010 | US7745578 a mixture of a heat shock protein and a carrier, used to promote migration of cells from stents and specific sites including sites of inflammation, infection, an autoimmune reaction, a tumor and a transplanted organ or tissue |
| 06/29/2010 | US7745466 Magnesium salt of S-omeprazole trihydrate of crystal form and another drug such as NSAID, antibiotic, antacid, alginates or prokinetic agents; gastric acid secretion inhibitor, and is useful as an antiulcer agent |
| 06/29/2010 | US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 06/29/2010 | US7745426 vitamin B6-based component selected from pyridoxal, pyridoxamine or pyridoxine chemically linked to antiepileptic agents, neuroprotectants, neurotransmitters or nootropic agents, used for the treatment of epilepsy |
| 06/29/2010 | US7745416 Method for in vivo regulation of cardiac muscle contractility |
| 06/29/2010 | US7745157 Enhancing an immune response to an antigen in a mammal by administering lymphocyte conditioned median based on a mixture of cytokines and chemokines obtained from peripheral blood mononuclear cells stimulated with antiCD3/CD28-coated beads; used with traditional vaccines or cancer immunotherapy |
| 06/29/2010 | US7744933 Use of unsaponifiable components of vegetable oils for preparing a cosmetic and related treatments |
| 06/29/2010 | US7744908 Allowing full spoon filling for accurate pharmaceutical dosage; storage stability |
| 06/29/2010 | US7744889 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents |
| 06/29/2010 | US7744864 Method for identifying a patient at risk of having difficulty in sustaining a pregnancy |
| 06/29/2010 | CA2442881C New process for the industrial synthesis of the tetraesters of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis ofbivalent salts of ranelic acid and their hydrates |
| 06/24/2010 | US20100160213 Antimicrobial and anticancer lipopeptides |
| 06/24/2010 | US20100158972 Method for reducing the likelihood of preterm labor in a subject in need thereof |